Robson ME, Im SA, Senkus E, et al. OlympiAD: Phase III trial of olaparib monotherapy versus chemotherapy for patients (pts) with HER2-negative metastatic breast cancer (mBC) and a germline BRCA mutation (gBRCAm). J Clin Oncol 35, 2017 (suppl; abstr LBA4).
Nivolumab bij gevorderd hepatocellulair carcinoom: CheckMate 040
jul 2017 | Immuuntherapie, Maag-darm-leveroncologie